Gemelli Biotech is proud to partner closely with the Medically Associated Science and Technology (MAST) program at Cedars-Sinai in Los Angeles, ranked by US News and World Report as one of the top 10 hospitals in the nation. MAST is dedicated to the development of diagnostics and therapeutics for conditions of the microbiome.
Partnership with MAST allows Gemelli to operate on the cutting edge, with an early look at the newest scientific discoveries related to the microbiome.
Visit the Cedars-Sinai Website
Visit the MAST Website
INTERNATIONAL CLINICAL LABORATORIES
Gemelli Biotech partners with clinical laboratories around the world to make ibs-smart available internationally.
Our list of partnerships is growing consistently and ranges from Swizerland (Unilabs) to Mexico (Biomedica) to Japan (CA Nutrients).
To see a complete, current list of lab partnerships for ibs-smart visit the ibs-smart website